COUGH AND RUB

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 咳嗽是美国急诊医生就诊的最常见原因，也可能是患有上呼吸道感染(URI)的儿童最令人烦恼的症状。这在晚上尤其麻烦，因为它会对咳嗽的孩子和他们的父母的睡眠产生不利影响。最近的研究和发布的指南质疑了许多口服非处方药治疗咳嗽和感冒症状的有效性。这给父母和患者留下了有限的治疗选择。这项研究旨在主观评估Vicks VapoRub软膏(VVR)和对照软膏(凡士林)在控制URI儿童夜间咳嗽和感冒症状方面是否比根本不治疗更好。它还将确定治疗对URI儿童及其父母睡眠质量的影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cough is the most common reason for an acute care doctor's visit in the United States and may be the most bothersome symptom for children with upper respiratory tract infections (URI). It is particularly troublesome at night because it can adversely affect sleep for both coughing children and their parents. Recent studies and published guidelines have questioned the efficacy of many of the oral over-the-counter treatments for cough and cold symptoms. This has left parents and patients with limited therapeutic options. This study seeks to subjectively evaluate whether Vicks¿ VapoRub¿ (VVR) ointment and a control ointment (petrolatum) are better than no treatment at all for controlling nocturnal cough and cold symptoms in children with URI. It also will determine the effect of the treatments on sleep quality for children with URI and their parents.